Seronegative spondyloarthropathy Flashcards
(50 cards)
What is a seronegative spondyloarthropathy? (just read)
How are they divided? (two types)
Seronegative spondyloarthropathies are inflammatory disorders involving predominantly the axial skeleton, possibly with peripheral joint involvement and characteristic extra-articular features.
Defined according to:
1) Axial spondyloarthritis (SpA)
○ Predominantly affects axial skeleton - spine, SIJ
○ If there is radiographic sacroiliitis -> ankylosing spondylitis
○ If there is no radiographic sacroiliitis -> non-radiographic axial spondyloarthritis
2) Peripheral spondyloarthritis
○ Predominantly affecting peripheral joints, entheses, or dactylitis.Has overlap with psoriatic arthritis as per CASPAR classification
ASAS classification criteria for Axial spondyloarthritis?
• All patients need to have ≥3 months inflammatory back pain + age of onset <45yrs
• You can then meet classification of axial spondyloarthritis down a clinical or radiologic pathway if you have additional following features:
• Clinical pathway: HLAB27 +ve AND ≥2 SpA features (inflammatory back pain, arthritis, enthesitis, urevitis, dactylitis, psoriasis, IBD, good response to NSAIDS, family history of SpA, elevated CRP, HLAB27)
• Radiological pathway: sacroiliitis on imaging according to modified New York criteria AND ≥1 SpA feature.
○ All individuals who have definite evidence of sacroiliitis according to New York Criteria on plain film, and meet these classification criteria, by definition have ankylosing spondylitis.
○ Active inflammation on MRI highly suggestive of sacroiliitis associated with spondyloarthritis.
ASAS classification of peripheral spondyloarthritis?
• Evidence of peripheral arthritis and/or enthesitis and/or dactylitis PLUS ○ ≥1 extra-articular extra-spinal feature: § Uveitis § Psoriasis § IBD § Preceding infection § HLAB27 § Sacroiliitis on imaging ○ ≥2 other SpA features § Arthritis § Enthesitis § Dactylitis § Inflammatory back pain § Family history of SpA
Key features of seronegative spondyloarthropathies?
Key features of seronegative spondyloarthropathies:
• Hallmark feature is enthesitis eg, Achilles tendon, plantar fascia, tendon insertion points in DIP
• Dactylitis (due to flexor tenosynovitis of the digit) or other axial skeleton involvement
• Sacroilitis
• Peripheral joint involvement is usually asymmetric large joint oligoarthritis, but can be polyarticular
Features of inflammatory back pain
Features of inflammatory back pain: • Insidious onset • Morning stiffness >30min • Pain improving with movement, worsening with rest • Alternating buttock pain • Nocturnal waking second half of night • Responsive to NSAIDS • Age <40 • >3 months
Key differentiating features of different seronegative spondyloarthropathies according:
- age of onset
- male to female predeliction
- peripheral vs. axial joint involvement
- dactylitis
- enthesitis
- psoriasis
- nail lesions
- HLAB27
Key differentiating features: • Age of onset: ○ AS - 20s ○ Psoriatic arthritis, reactive, enteropathic - 30s • Male to female ratio: ○ AS - male > female ○ Psoriatic arthritis - male = female ○ Reactive arthritis - male > female if Chlamydia induced, but male = female if dysentery induced ○ Enteropathic - male > female • Peripheral vs. axial joint involvement ○ Psoriatic - peripheral common, ~96%; axial less common ~50% but unilateral sacroiliitis is characteristic ○ AS - axial prominent presentation (100%), peripheral less prominent than axial ~30% ○ Reactive arthritis - peripheral and axial involvement both common, 90% and 100% respectively ○ Enteropathic - roughly equal but sacroiliitis most common manifestation • Dactylitis ○ Psoriatic arthritis - common ○ AS - absent ○ Reactive arthritis - uncommon ○ Enteropathic - absent • Enthesitis ○ Psoriatic - common ○ AS - common ○ Reactive - uncommon ○ Enteropathic - uncommon • Psoriasis ○ Psoriatic - common 100% of cases ○ AS, reactive, enteropathic, ~10% of cases. • Nail lesions ○ Psoriatic - common 87% ○ Uncommon in others • HLAB27 ○ Psoriatic ~50% ○ AS ~90% ○ Reactive ~30-50% ○ Enteropathic ~30%
General statement of ankylosing spondylitis? (just read)
What does the prevalence of AS in a population depend on?
Men vs. women?
Most common decade of onset?
a chronic progressive inflammatory spondyloarthropathy predominantly affecting young males resulting in sacroiliitis and axial skeleton involvement, with strong association with HLAB27, which ultimately may lead to spinal fusion. Other features include a peripheral arthritis, enthesitis, and other extra-articular manifestations including eye, bowel, and skin involvement.
Epidemiology:
• Prevalence in population depends on HLAB27 prevalence in the population.
• Men > women
• Most commonly presents 2nd decade of life
Read about the pathophysiology of AS. Key points to remember:
- HLAB27
- role of IL23 and ERAP1
- bone erosion vs. bone formation, Wnt, IL22, IL17
Pathophysiology:
• Strong genetic component
○ HLAB27 present in 90% of AS; 6.5% of HLAB25 develop AS. Role of AS remains unclear.
○ IL23 receptor and endoplasmic reticulum aminopeptidase 1 (ERAP1) also important in pathophysiology. ERAP1 encodes a peptidase which influences antigen presentation to HLAB27
• AS involves inflammation, erosion + repair (ossification). Cf. RA where inflammation and erosion are the only pathological processes, not ossification. Leads to osteoproliferative process resulting in a healing osteitis, which leads to ossification of outer fibres of annulus fibrosis, creating a syndesmophyte (margina, unlike non-marginal syndesmophyte of reactive arthritis)
• Theory that inflammation and new bone formation are uncoupled. Upregulation of Wnt via TNF mediation is likely to be responsible for new bone formation. IL22 and IL17 pathways also involved in bone erosion and formation. It is postulated that new bone formation at sites of enthesitis is a repair mechanism.
Risk factors for AS
Risk factors:
• HLAB27 +ve in 90% of AS patients; 6.5% of HLAB27 have AS
• ERAP1 and IL23R genes
• +ve family history for AS
• Klebsiella pneumonia - speculated to play a role in AS, unclear.
What is required for definite diagnosis of AS?
How long does changes of sacroiliitis take to develop?
What is a definite diagnosis of AS as per modified New York Criteria?
Require definite evidence of sacroiliitis on plain radiograph for diagnosis of AS, however plain film changes represent well-established damage and may take years to develop.
Definite AS if sacroiliitis as below + one of:
○ Inflammatory back pain >3 months
○ Limited lumbar spinal motion
○ Chest expansion decreased relative to normal values for sex and age
Sacroiliitis = bilateral sacroiliitis grade 2-4 OR unilateral sacroiliitis grade 3-4
Clinical presentation of AS
History
• Inflammatory back pain, age 20-30, typically men
• Peripheral joint involvement (~30%)
○ Eg, hip joint, costovertebral joints
○ Usually asymmetric oligoarthritis of lower limb large joints
○ Women tend to have more peripheral arthritis and cervical involvement, radiographic severity is lower.
• Extra-articular manifestations:
○ Iritis, uveitis - common. 40% of patients with AS develop iritis. 50% of all patients with iritis are HLAB27 +ve. Uveitis is more common in AS than in non-radiographic axial spondyloarthropathy, in contrast to other extra-articular manifestations
○ Enthesitis - common. Eg, plantar fascia, heel (Achilles), knee, ischial tuberosities
○ Psoriasis ~10% of AS patients. Very important that AS patients found with concomitant psoriasis are not classified as having psoriatic spondylitis or arthritis.
○ IBD ~10% of AS patients. Subclinical bowel inflammation histologically detectable in 60% of cases.
○ Dyspnoea - may be due to costochondral involvement limiting chest expansion, spinal kyphosis causing restrictive lung deficit, upper lobe pulmonary fibrosis
○ Constitutional symptoms
○ Aortitis, aortic regurgitation, arrhythmias, accelerated IHD
• Extra-articular manifestations are the same in AS & non-radiographic axial spondyloarthropathy with exception of uveitis which is more common in AS.
Examination
• Loss of lumbar lordosis - classic examination finding
• Reduced lumbar flexion, lateral flexion
• Decreased cervical rotation
• Increased tragus to wall test (indicates decreased cervicothoracic mobility)
• Tenderness at sacroiliac joints
• Kyphosis (in chronic cases)
• Peripheral joint involvement
• Features of other extra-articular manifestations as above
Describe the radiographic changes of sacroiliitis on plain film in AS
Is it typically unilateral or bilateral? What about in other spondyloarthropathies?
Does a -ve plain film excldue diagnosis of AS? Why?
Radiographic severity in women, is it higher or lower?
• Plain film of pelvis
○ Confirm radiographic sacroiliitis. Sacroiliitis typically bilateral, but less commonly can be unilateral (unilateral more common in other spondyloarthropathies). Graded 1-4. they widen before they narrow, and end-stage SIJ undergoes ankylosis and is no longer visible. There is associated subchondral erosion & sclerosis on iliac side of SI joint.
§ Early changes: erosions, sclerosis at joint margins
§ Later: pseudo-widening
§ Last: joint space narrowing, progressing to ankylosis
○ A negative X-ray does not exclude AS as radiographic changes take years to develop.
○ Radiographic severity is lower for women
If there is normal pelvic X-ray for AS, what might an MRI show? What sequences should you order?
• If normal pelvic X-ray, consider MRI if history consistent. May be non-radiographic axial spondyloarthropathy.
○ Order T1 and STIR images.
○ STIR images are T2 weighted fat suppressed images. Can detect active inflammation as evident by subchondral bone marrow oedema.
○ T1 images can detect post-inflammatory lesions: erosions, sclerosis, ankylosis, fatty lesions.
○ Sequence of events: bone marrow oedema is inflammatory lesion. These evolve into repair lesions (fatty lesions on MRI) from which stimuli for new bone formation are released. New bone formation (syndesmophyte) arises.
What will you see on lumbar, thoracic, and cervical spine X-rays in AS?
• Also perform lumbar, thoracic, and cervical spine X-ray s as a baseline. May see:
○ Erosions, typically corners of vertebral bodies with reactive sclerosis
○ Vertebral body squaring
○ Romanus lesion “shiny corner” - entheseal site with underlying bone marrow oedema, site of new bone formation.
○ Syndesmophytes - osseous excrescence attached to ligament, typically marginal, later progress to bridging syndesmophyte
○ Bamboo spine in late disease (diffuse syndesmophytic ankylosis)
○ Note: ankylosis = fusion
In AS, what is US used to confirm?
• Ultrasound may be used to confirm enthesitis
What proportion of AS have HLAB27? What proportion of HLAB27+ve patients have AS?
ESR and CRP elevation is associated with what in AS?
○ HLAB27: 90% of AS +ve; 6.5% of HLAB27 have AS.
ESR and CRP may be elevated, associated with spinal radiographic progression. Hence has prognostic value. Also, if elevated more likely to be responsive to biologics.
Osteoarthritis vs. AS?
DISH vs. AS?
Psoriatic arthritis vs. AS?
Reactive arthritis vs. AS?
Enteropathic arthritis vs. AS?
DDx
• Osteoarthritis - history consistent with mechanical back pain rather than inflammatory. Radiographs demonstrate degenerative disc disease and presence of osteophytes
• Diffuse idiopathic skeletal hyperostosis (DISH): typically mechanical symptoms. Age of onset is ~50-75 which is in contrast to AS. In DISH, there are flowing osteophytes along anterior margin of vertebra in the presence of normal vertebral bodies and discs.
• Psoriatic arthritis: age group is typically 35-45, no sex bias, sacroiliitis may be unilateral, dactylitis is more common, and history of psoriasis. Hand and foot X-rays may have erosive disease.
• Reactive arthritis: specific infection, dactylitis more common, skin involvement, (keratoderma blenorrhagicum, circunate balanitis), conjunctivitis, sterile urethritis, may have unilateral sacroiliitis
• Enteropathic arthritis: history of IBD, no sex bias, peripheral joint involvement more common, may have evidence of other extra-intestinal manifestations of IBD such as erythema nodosum and pyoderma gangrenosum, only 30% HLAB27 +ve, may have unilateral sacroiliitis.
Predictors of spinal radiographic progression in AS?
Predictors of spinal radiographic progression
• Syndesmophytes on baseline radiographs
• Elevated ESR and CRP
• Smoking
Do any treatments stop progression of joint fusion in AS?
No
Management of AS
Management
• No treatments induce remission. No treatments stop progression of joint fusion.
• Non-pharmacologic
○ Physiotherapy - essential to improve and maintain posture, flexibility, and mobility. There is evidence to support efficacy of hydrotherapy.
○ Patient education
○ Smoking cessation - reduce risk of radiographical progression & reduce CV risk.
• Pharmacologic
○ NSAIDS
§ First line treatment for symptomatic disease
§ Evidence for improvement in outcome measures & slows radiographic progression in AS with regular use (studies show slowing of radiographic progression if regular use over 2 years) particularly if higher risk for radiographic progression (baseline syndesmophytes & elevated ESR/CRP). However, benefit not shown in non-radiographic axial spondyloarthropathy likely due to low natural rate of radiographic progression in this patient subgroup.
§ Use largest tolerated dose before switching to another NSAID. COX2 inhibitors also can be used. Etoricoxib superior to other NSAIDS for pain.
§ Both non-selective and COX2 selective inhibitors increase CV morbidity.
§ Watch for adverse effects: GI bleeding (Rx with PPI), renal impairment
○ Intra-articular corticosteroid injections
§ For localised inflammation eg, unilateral sacroiliitis , Achilles enthesopathy, etc.
○ DMARDS
§ Sulfasalazine - only effective for peripheral arthritis. No benefit in axial disease. No benefit for slowing radiographic progression.
§ No evidence to support use of methotrexate or leflunomide.
○ TNF-a inhibitors & other biologics
§ TNF-a inhibitor agents
□ Infliximab
□ Adalimumab
□ Etanercept
□ Golimumab
□ Certolizumab pegol
§ TNF-a inhibitors significant improvement in symptoms, function, and inflammation demonstrated on MRI. Prevents radiographic progression after 2 years (not within first 2 years). Also has benefit in non-radiographic axial spondyloarthropathy. Maintain long-term response over 5 years.
§ Secukinumab
□ Anti-IL17A antibody. IL17 is produced by Th17 cells and is a pro-inflammatory cytokine implicated in autoimmune and inflammatory diseases.
□ Significant improvement in symptoms, function. Can be used as 2nd line if NSAIDS fail, or 3rd line if TNF-a inhibitor fails
○ Pamidronate
§ Treatment option if patient unsuitable for treatment with TNFa inhibitor.
§ May reduce IL1, IL6, and TNF-a cytokines.
• Surgery
• Cardiovascular risk management
○ Mortality for AS is higher than general population, largely attributable to excess cardiovascular disease, particularly ischaemic heart disease from accelerated atherosclerosis.
• Treatment for different types of disease
○ Pain and stiffness
§ NSAIDS
§ Intra-articular corticosteroid injections
§ If refractory:
□ 2nd line
® TNF-a inhibitor
® Secukinumab
□ 3rd line
® IV pamidronate
○ Peripheral joint involvement
§ DMARDS - sulfasalazine.
○ Adults with refractory disease
§ TNF-a inhibitors
○ Non-radiographic axial spondyloarthritis
§ NSAIDS
§ 2nd line: TNF-a inhibitor.
Read about emerging treatments for AS
• Emerging
○ Ustekinumab
§ Antibody against IL12 and IL23. IL23 is a cytokine which binds to IL23 receptor on Th17 cells and promotes Th17 differentiation and proliferation.
§ Effective in mod-severe psoriasis.
§ Trials also showing efficacy in active AS
§ However, RACP lecture stating ineffective for spondylitis.
○ Apremilast
§ Oral phosphodiesterase 4 inhibitor. Possible efficacy but not statistically significant.
○ Rituximab
§ Anti-CD20, B-cell depleting agent. Demonstrated efficacy in anti-TNFa naïve patients. No efficacy if previously refractory to anti-TNFa
Complications of AS
Complications
• Osteoporosis
○ Common, 10% of patients have vertebral fractures.
• Cardiac involvement
○ Excess ischaemic heart disease due to accelerated atherosclerosis
○ Aortitis
○ Aortic regurgitation
○ Arrhythmias
• Iritis/uveitis
○ Common - around 40% of patients with AS.
○ 50% of patients with iritis will be HLAB27 +ve
• Pulmonary involvement
○ Apical pulmonary fibrosis - rare
○ Costovertebral involvement - can cause restrictive deficit on RFTs
What proportion of AS patients have progressive disease leading to fusion of SIJ and bamboo spine?
20%
What are poor prognostic factors in AS?
Frequent bouts of iritis/uveitis
Hip involvement at presentation
Peripheral joint involvement
Elevated ESR/CRP